Evommune, Inc. (EVMN) stock
EVMNNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$7.02−0.08 (-1.13%)
Close on Nov 17, 2026Market cap $254.77MP/E –Yield –
Evommune price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Evommune's price to sales ratio was 31.3× on Nov 11, 2026, against 2.5× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 31.3× | +29.2 |
| 2025 | Dec 31, 2025 | 2.0× | – |
See a number that looks wrong?